Tokyo, Aug. 2 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058659) titled 'Complication prevention measures for high-risk cases of stricture after endoscopic submucosal dissection' on Aug. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Tobata Kyoritsu Hospital
Condition:
Condition - stomach cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - We aim to clarify the current status of stenosis after gastric ESD at our hospital and the usefulness of concomitant steroid use, and to consider treatment strategies for high-risk cases of stenosis.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Between April 1, 2004 and June 30, 2024, 1,207 cases of ESD were performed for gastric epithelial and submucosal tumors at our hospital.
Of these, 148 cases were cardia and pylorus cases, and 3 cases in which the progress could not be followed were excluded, so 145 cases were examined.
Key exclusion criteria - Cases in which the presence or absence of stenosis after ESD could not be confirmed
Target Size - 145
Recruitment Status:
Recruitment status - No longer recruiting
Date of protocol fixation - 2024 Year 02 Month 01 Day
Date of IRB - 2024 Year 09 Month 01 Day
Anticipated trial start date - 2024 Year 04 Month 01 Day
Last follow-up date - 2025 Year 06 Month 30 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066994
Disclaimer: Curated by HT Syndication.
